Check out the companies that make headlines after the bell on Tuesday:
Atlassian – Shares of Australian software company up 1% from revised revenue guidelines for the third fiscal quarter. Atlassian now expects revenues of between $ 566 million and $ 572 million. Analysts surveyed by FactSet previously predicted revenue of $ 487.2 million for the company’s third quarter. The new forecast is also above the previous Atlassian revenue guide for that quarter.
Stitch Fix – Shares of the personal styling service fell 3.2% after the company announced that founder and CEO Katrina Lake would become chief executive and Elizabeth Spaulding would take over as CEO on August 1.
Endo International – The pharmaceutical company’s shares rose slightly after the company announced that promising Phase 3 cellulite treatment data had been published in the official journal of the American Society of Dermatological Surgery. The data showed that treatment provided a clinically significant improvement in the appearance of moderate to severe cellulite in the buttocks in adult women compared to placebo.
Amicus Therapeutics – The biopharmaceutical company’s shares rose 3% after Cantor Fitzgerald analysts updated the stock to neutral overweight, citing the company’s promising results in gene therapy.
Discovery – Discovery Class A and Class C shares fell 3.8% and 5.1%, respectively, after after David Faber of CNBC reported that Credit Suisse continues to unload positions in the media company due to the explosion Capital Management Archives. Citing retailers, Credit Suisse sold 19 million of the company’s Class A shares and 22 million of Class C shares.